HUMORAL RESPONSES TO PIG-TO-BABOON CARDIAC TRANSPLANTATION - IMPLICATIONS FOR THE PATHOGENESIS AND TREATMENT OF ACUTE VASCULAR REJECTION AND FOR ACCOMMODATION
Kr. Mccurry et al., HUMORAL RESPONSES TO PIG-TO-BABOON CARDIAC TRANSPLANTATION - IMPLICATIONS FOR THE PATHOGENESIS AND TREATMENT OF ACUTE VASCULAR REJECTION AND FOR ACCOMMODATION, Human immunology, 58(2), 1997, pp. 91-105
Organs transplanted between phylogenetically-disparate species, such a
s from the pig into the primate, are subject to hyperacute and acute v
ascular rejection. Hyperacute rejection of a porcine organ by a primat
e is thought to be initiated by the binding of xenoreactive natural an
tibodies to Gal alpha 1-3Gal expressed on the endothelial lining of bl
ood vessels in the xenograft. The factor(s) which initiates acute vasc
ular rejection is uncertain; however, there is some evidence implicati
ng xenoreactive antibodies. The nature of the humoral response which m
ight contribute to acute vascular rejection of a porcine organ was inv
estigated in baboons which received a porcine cardiac xenograft plus i
mmunosuppression with methylprednisolone, azathioprine and cyclosporin
e. Following rejection and surgical removal of the xenografts, the ser
um concentration of xenoreactive antibodies increased in untreated ani
mals but in immunosuppressed animals was similar to the concentration
in preimmune serum. The antibodies in the sensitized recipients were s
pecific for Gal alpha 1-3Gal (70-95%) and other determinants (5-30%).
However, cross-blocking studies showed that, following xenotransplanta
tion, the immunosuppressed baboons had no detectable IgM or IgG direct
ed against ''new'' endothelial antigens. These results indicate that a
ntibodies made by immunosuppressed individuals in response to xenotran
splantation are much like xenoreactive natural antibodies and suggest
that acute vascular rejection might in some cases be addressed by ther
apeutic strategies antibodies. (C) American Society for Histocompatibi
lity and Immunogenetics, 1997, Published by Elsevier Science Inc.